Example: Heart Attack
Search clinical trials for: Maitake
Total 2 results
-
NCT02603016CompletedConditions: Lung Neoplasms, Breast Neoplasms
-
NCT01099917CompletedConditions: Myelodysplastic Syndrome
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Adult Diffuse Astrocytoma
- Cerebral Small Vessels Disease
- Drinking Heavy
- Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy
- Framingham Risk Score More Than 20 Percent
- Gastro-esophageal Reflux Disease With Ulceration.
- Hamstring Rupture
- Low Grade Dysplasia in Barrett Esophagus
- Malocclusion, Angle's Class
- Pancreas Cancer, Stage III
- Recurrence Hepatocellular Carcinoma
- Surgical Field
- Urothelial Cancer
- View Full List
Sponsors and Collaborators
- Beijing Kantorico Statistical Technology Co., Ltd.
- Birdie Biopharmaceuticals HK Limited
- Canadian Foundation for Dietetic Research (CFDR)
- Dartmouth College
- DongKoo Bio & Pharma
- Dr. Franco Molteni
- Health Beacons
- Hospital Donostia
- Institut Universitari Dexeus
- Medical College Baroda
- Ruikang Hospital affiliated to Guanxi University of Chinese Medicine
- St Olavs Hospital University Hospital in Trondheim
- Vent-axia Ltd
- View Full List
Drug Interventions
- 0.04% PHMB
- Aerosolized Intranasal midazolam
- Budesonide + Salmeterol + Placebo
- Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
- IV Dalbavancin
- Levomepromazine
- Lidocaine-prilocaine cream
- Nootropics (ginkgo biloba, nicergoline, piracetam, or others)
- PD-1 monoclonal antibody injection
- Single Ascending Dose (SAD) Cohorts GS-9620
- Tegafur-uracil (UFT)
- UCN-01 (7-hydroxystaurosporine)
- YYD601 1
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations